Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Daily use of Schering-Plough’s nasal spray proves effective
Nasal polyps are grape-like growths in the nasal cavity that can reduce airflow in the nasal passages, leading to congestion. If unresolved, surgery may be needed to remove
Nasal polyps are grape-like growths in the nasal cavity that can reduce airflow in the nasal passages, leading to congestion. If unresolved, surgery may be needed to remove
Under the terms of the agreement, CiVentiChem will provide research services in the areas of medicinal chemistry, custom compound synthesis and process development. Both CiVentiChem US facility and
The study shows that patients with a rare and potentially deadly blood disease, paroxysmal nocturnal hemoglobinuria (PNH), who received eculizumab maintained significant reductions in red blood cell destruction
Although Zyflo has been approved for sale since 1996, Critical has not been able to launch the drug due to manufacturing problems. The company is still in the
A total of 38 cases of blindness caused by non-arteritic anterior ischemic optic neuropathy (NAION) were reported to the FDA during May 2005. Although this condition was at
Transneuronix is the creator of an implantable pacemaker-like device that delivers electrical pulses to the stomach. The acquisition follows the formation of Medtronic’s new business unit, Medtronic Obesity
Around 75% of all postmenopausal cases of breast cancer are linked to estrogen. It is this patient population who will now be able to benefit from the use
A pilot bioequivalence study has been completed and scale up will begin shortly. Elite will manufacture the product and Pliva will market and sell the drug. The development
The biologics division at the FDA issued a warning letter to MedImmune’s vaccines unit claiming that the leaflet promoting the company’s nasal spray was misleading. The company removed
Already in clinical trials, Reolysin, a reovirus-based therapy from Oncolytics Biotech, will soon be administered to patients with metastatic tumors in a company-sponsored phase I trial. Reoviruses are